Sequencing and characterization of the FVB/NJ mouse genome by Kim Wong et al.
RESEARCH Open Access
Sequencing and characterization of the FVB/NJ
mouse genome
Kim Wong1, Suzannah Bumpstead1, Louise Van Der Weyden1, Laura G Reinholdt2, Laurens G Wilming1,
David J Adams1* and Thomas M Keane1*
Abstract
Background: The FVB/NJ mouse strain has its origins in a colony of outbred Swiss mice established in 1935 at the
National Institutes of Health. Mice derived from this source were selectively bred for sensitivity to histamine
diphosphate and the B strain of Friend leukemia virus. This led to the establishment of the FVB/N inbred strain,
which was subsequently imported to the Jackson Laboratory and designated FVB/NJ. The FVB/NJ mouse has
several distinct characteristics, such as large pronuclear morphology, vigorous reproductive performance, and
consistently large litters that make it highly desirable for transgenic strain production and general purpose use.
Results: Using next-generation sequencing technology, we have sequenced the genome of FVB/NJ to
approximately 50-fold coverage, and have generated a comprehensive catalog of single nucleotide polymorphisms,
small insertion/deletion polymorphisms, and structural variants, relative to the reference C57BL/6J genome. We
have examined a previously identified quantitative trait locus for atherosclerosis susceptibility on chromosome 10
and identify several previously unknown candidate causal variants.
Conclusion: The sequencing of the FVB/NJ genome and generation of this catalog has increased the number of
known variant sites in FVB/NJ by a factor of four, and will help accelerate the identification of the precise
molecular variants that are responsible for phenotypes observed in this widely used strain.
Background
The origins of the FVB/NJ line can be traced back to an
outbred colony of Swiss mice (N:GP, NIH general pur-
pose) established at the National Institutes of Health
(NIH) in the 1930s. A second colony (N:NIH) was subse-
quently established from the N:GP strain in the 1940s and
then in the 1960s two new sub-lines (HSFS/N and HSFR/
N) were established by selecting for sensitivity to hista-
mine diphosphate challenge following pertussis vaccina-
tion. After eight generations of inbreeding, histamine-
sensitive mice (HSFS/N) were found to carry the Fv-lb
allele for sensitivity to the B strain of Friend leukemia
virus [1,2]. These mice were bred to homozygosity and
designated as the FVB/N inbred strain. FVB/N mice were
imported to the Jackson Laboratories in 1988 at F37 and
in 1991 were re-derived at N50 for addition to the Jackson
foundation stocks. The FVB/NJ mouse has since become
the workhorse of many mouse genetics laboratories due to
its high reproductive performance, large litter sizes, and
prominent pronuclei in fertilized eggs that make it an
ideal strain for transgenic strain production [1,3]. FVB/NJ
also represents an important disease model, and this strain
has been used in a range of congenic and inter-strain
crosses to identify disease-causing genes.
One well known phenotype of FVB/NJ mice is early
onset retinal degeneration, which has been attributed to
a nonsense mutation in the Pde6b gene [4]. FVB/NJ mice
also fail to secrete complement 5 due to a 2-bp deletion
in the Hc gene, which causes a truncation of the protein
[1,5]. Resistance to collagen-induced arthritis, observed
in FVB/NJ, has been shown to be due to a single nucleo-
tide polymorphism, a 3-bp indel, and a large deletion in
the T-cell receptor variable regions [6]. FVB/NJ mice also
display a number of phenotypes relating to human dis-
ease, including susceptibility to seizures, diseases of the
central nervous system [7], mammary hyperplasia [8] and
with age, the spontaneous development of tumors in a
range of organs, most commonly in the lung [9]. In addi-
tion, FVB/NJ mice are highly susceptible to chemically
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induced skin tumors [10], and are resistant to athero-
sclerosis [11].
Recent advances in sequencing technologies have
reduced the cost of genome resequencing to a fraction of
the cost required to produce the C57BL/6J mouse refer-
ence genome [12,13]. Next-generation sequencing tech-
nologies have been used to sequence the genomes of 17
common laboratory mouse strains, providing the most
detailed picture of molecular variation between mouse
strains to date [14,15]. This resource has already been
used to accelerate the process of identifying candidate
functional variants [16]. To complement this resource we
sequenced the FVB/NJ genome. Here we describe a high
quality catalogue of SNPs, insertion/deletion polymorph-
isms (indels) and structural variants (SVs) for this impor-
tant strain. We compare these variants to those discovered
in the 17 mouse genomes to profile the level of private
variation in this strain, and demonstrate how our catalo-
gue of FVB/NJ variants can be applied to identify and
prioritize putative causative variants at quantitative trait
loci (QTL) by examining the chromosome 10 athero-
sclerosis susceptibility locus, Ath11.
Results and discussion
SNPs and indels in the FVB/NJ genome
The FVB/NJ mouse genome was sequenced to a depth of
approximately 50-fold coverage using 100-bp paired-end
reads generated by the Illumina HiSeq 2000 sequencing
platform [17] (European Nucleotide Archive accession
ERP000687). The sequencing reads were mapped to the
C57BL/6J mouse reference genome (NCBIM37/mm9)
with BWA [18], followed by local realignment of reads
around indels discovered by the Mouse Genome Project
(MGP) using the Genome Analysis Toolkit (GATK) [19].
SNP and indel discovery was performed using the SAM-
tools mpileup function and BCFtools [20] (dbSNP handle:
SC_MOUSE_GENOMES).
We have generated a catalogue of approximately 4.3 mil-
lion high-confidence SNPs from the FVB/NJ sequence
data (Figure 1). We randomly selected SNPs from this cat-
alogue for genotyping using the Sequenom MassARRAY
iPLEX Gold Assay [21] (Materials and methods), and esti-
mate the false positive rate to be <1.6% (2/127; Materials
and methods). We also compared our catalogue of SNPs
to the list of FVB/NJ genotyped sites from the Perlegen/
National Institute of Environmental Health Sciences
(NIEHS) SNP set [22]. There are 996,981 homozygous
non-reference SNPs for FVB/NJ in this data set, and of
these, 91.7% (914,225) are present in our FVB/NJ catalo-
gue. Of the 8.3% of SNPs that were not found in our FVB/
NJ SNP catalogue, 2.7% were at sites classified as inacces-
sible (Materials and methods) and 5.6% were at accessible
sites. To investigate this 5.6% discrepancy, we randomly
selected sites from this list for genotyping using the iPLEX
Gold Assay. The assays showed that a homozygous refer-
ence genotype was present at 96.8% (90/93) of the sites,
suggesting that these are incorrectly genotyped as non-
reference SNPs in the Perlegen/NIEHS data set. Taking
this into consideration, we estimate that the majority of
the 5.6% of SNPs in accessible regions that are not in our
FVB/NJ catalogue are actually homozygous reference
alleles, and therefore our false negative rate for accessible
sites genotyped in the Perlegen/NIEHS study is <1%. It is
important to note, however, that genome-wide the overall
false negative rate will be higher as a large number of
SNPs will fall in high copy repeats such as transposable
elements and regions of low complexity [14].
We have also catalogued 0.82 million small indels in the
FVB/NJ genome. The 0.38 million insertions range in size
from 1 bp to 34 bp and 0.44 million small deletions range
in size from 1 bp to 56 bp. We also used iPLEX Gold
Assay to estimate the false positive rate of our indels. We
tested a random sample of 100 short indels and estimate
the false positive rate to be 10.1% (Materials and methods).
Functional consequences of SNPs and indels
Using the Variant Effect Predictor from Ensembl [23],
we assigned putative functional consequences to the var-
iants found in FVB/NJ (Table 1). As expected, the
majority of the SNPs do not fall inside of genes; just
over half (2,247,487 SNPs, 52.1%) are classified as inter-
genic (>5 kb upstream or downstream of a gene), and
12.4% are within 5 kb of a protein-coding gene (345,321
SNPs) or non-coding gene (163,280 SNPs). Of particular
interest are SNPs that affect splice sites and protein-
coding regions, such as non-synonymous substitutions
and those that generate or destroy stop codons. Based
on Ensembl version 64 gene models, the number of
SNPs causing either a premature stop codon or a stop
codon loss was 71 and 16 SNPs, respectively. However,
upon manual inspection of these sites, we were able to
eliminate a number of these as true stop-gain and stop-
loss variants due to incorrect gene models; these genes
appear to be pseudogenes, non-coding genes, or artifacts
(Tables S1 and S2 in Additional file 1). Exclusion of
SNPs in these genes leaves 42 SNPs that generate a pre-
mature stop codon in all protein-coding transcripts of a
gene. By manual inspection, we predicted whether the
introduction of the premature stop codon would lead to
either the production of a truncated protein (24 SNPs)
or, if the premature stop codon is at least 50 bp
upstream of a splice junction, nonsense-mediated decay
(18 SNPs). Included in the list of true stop gain muta-
tions is the previously identified C®A transversion at
position 108,850,284 bp of chromosome 5 in the Pde6b
gene. FVB/NJ is one of several mouse strains known to
be homologous for this mutation, which has been
shown to cause early onset retinal degeneration [4]. Ten
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SNPs appear to cause the loss of a stop codon in FVB/
NJ (Table s2 in Additional file 1). Four of these are in
polymorphic pseudogenes, where the mutation is
actually a stop-gain in C57BL/6J. Manual inspection of
the 19 sites affecting splice sites revealed that only ten
of these actually affect the splice sites of valid protein-
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Figure 1 Distribution of SNPs, indels and structural variants in the FVB/NJ genome, relative to the reference C57BL/6J genome. Each
rectangle represents a chromosome of the mouse genome. Shown in the top panel of each chromosome is the ideogram representation,
followed by genome features, as indicated in the legend. SV, structural variant; TE, transposable element.
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coding genes (Table s3 in Additional file 1); however,
the effects of loss of the splice sites are difficult to
predict.
There are 3,453 genes in which one or more non-
synonymous SNPs affect all protein-coding transcripts
(7,880 non-synonymous SNPs). To predict whether the
amino acid substitutions would be deleterious, we
assigned a Grantham matrix score (GMS) for each substi-
tution. Only 5.2% of the non-synonymous substitutions
are considered to be radical (GMS >150), and 11.8% are
considered moderately radical (100 < GMS ≤ 150). We
performed functional annotation of the 394 genes with
radical substitutions using the Database for Annotation,
Visualization and Integrated Discovery (DAVID) web-
based tools [24,25], which showed a significant enrich-
ment of genes associated with the PANTHER molecular
function categories ‘G-protein-coupled receptor’
(P <1.5e-3), ‘Receptor’ (P <4.1e-3), and ‘KRAB box tran-
scription factor’ (P <4.5e-3) (Table 2). The genes in these
categories include several zinc finger proteins, olfactory
receptors and vomeronasal receptors.
Similar to the SNPs, the majority of FVB/NJ indels
are intergenic (50.4%) or within 5 kb upstream or
downstream of a gene (14.3%) (Table 1). Only a small
number of indels cause frameshifts (126) or in-frame
codon losses or gains (140), including the known ‘TA’
deletion in the hemolytic complement gene (Hc; start-
ing at position 34,898,728, chromosome 2), which is
associated with susceptibility to allergen-induced bron-
chial hyper-responsiveness [5]. Manual inspection of
the three indels predicted to affect splice sites revealed
that two of the affected genes are likely to be a pseudo-
gene and a long intergenic non-coding RNA, and the
third is built from an incorrect gene model (Table s3
in Additional file 1).
FVB/NJ private variants
We computationally determined the genotypes of the 17
MGP strains at all FVB/NJ variable SNP sites (Materials
and methods) to identify SNPs and indels unique to FVB/
NJ (’private’ SNPs and indels). To obtain a high-confi-
dence list, we classified a SNP site as private to FVB/NJ
only if all 17 MGP strains were called as high quality
homozygous reference alleles, as described for the FVB/NJ
data in the Materials and methods. Using these criteria,
we identified 115,228 private SNPs in FVB/NJ, which
is 2.7% of the total number of SNPs called in this strain
(Figure 1). From Sequenom genotyping of 103 sites, we
estimate the false positive rate for private SNPs to be 3.0
to 5.8% (Materials and methods).
Nearly half of the private SNPs (48.9%) are found in
intergenic regions, 21.2% are intronic, 8.6% are within 5 kb
upstream or downstream of a coding gene, and nearly
17.1% are predicted to have 2 or more functional conse-
quences. Among the remaining private FVB/NJ SNPs with
a single consequence, there are 358 non-synonymous
SNPs in 286 genes. Table 3 lists the private non-synon-
ymous sites with a GMS of at least 150, excluding genes
with unknown function (genes with Ensembl description
‘predicted gene’ and genes modeled from RIKEN cDNA).
Included in the list, with a GMS of 205, is a non-synon-
ymous substitution (C-to-A) in Scn10a, which changes a
cysteine to a phenylalanine at residue 1,678. Scn10a is a
voltage-gated sodium channel and mutations in this gene
have been shown to produce several phenotypes [26]. The
C-to-A substitution is located between two transmem-
brane regions at amino acid position 1,679 in an ion trans-
port domain (Pfam domain PF00520), which makes this
an interesting candidate for further functional studies.
There are eight private SNPs that create a premature stop
codon (Table s1 in Additional file 1), although manual
inspection of the sites revealed that three of these generate
truncated protein products (Olfr228, Sh3gl3 and Ighv14-3),
three generate transcripts targeted by nonsense-mediated
decay (Bpifb9a, Gm5155, H2-Ab1), while the remainder
fall inside of genes with invalid Ensembl gene models.
There are no variants private to FVB/NJ that cause the
loss of a stop codon. Of the 10 SNPs affecting splice sites
in the FVB/NJ genome, 3 are not found in the 17 MGP
strains (Spata21, Slc35a5, Gm4952).
Table 1 Predicted functional consequence of SNPs and
indels
Consequence SNPs Indels
5 kb upstream or downstream 345,321 86,229
5’ or 3’ UTR 19,402 3,769
Intronic 864,790 173,237
Synonymous coding 13,697 NA
Non-synonymous coding 7,880 NA
Essential splice site 10a (19) 0a (3)
Stop gain 42a (71) NA
Stop lost 6a (16) NA
In-frame codon insertion or deletion NA 140
Frameshift NA 126
Two or more consequences 689,535 136,895
Within non-coding gene or mature microRNA 115,453 22,735
5 kb upstream or downstream of non-coding gene 163,280 31,988
Intergenic (>5 kb from a coding or non-coding
gene)
2,247,487 416,289
A SNP or indel is annotated with a single consequence if the SNP or indel has
the same effect on all protein-coding transcripts of a gene. A SNP or indel has
two or more consequences if it has different effects on different transcripts of
a gene. For example, a SNP may be in the intron of one transcript, and a
synonymous SNP in a second transcript. Consequences were predicted using
the Ensembl Variant Effect Predictor (VEP) [23] and gene models from
Ensembl version 64. Note that a SNP may belong to more than one category.
For example, a SNP may be a synonymous SNP in one gene and also within
5 kb of a second gene. aThe number of true stop codon gain, stop loss, and
essential splice site consequences after manual inspection. The number in
parentheses is the predicted number from VEP (Tables s1, s2 and s3 in
Additional file 1). NA, not applicable.
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We also identified 8,172 private indels using the cri-
teria described above. Similar to the private SNPs, the
majority of private indels are intergenic (45.6%), intronic
(24.0%), within 5 kb of a coding gene (11.4%), or have
multiple consequences (18.0%). Only seven of these
affect all transcripts of a protein-coding gene: two are
in-frame codon insertions or deletions and five result in
frameshifts. All of the affected genes are olfactory recep-
tors, with the exception of an in-frame 3-bp deletion in
Hr, the hairless gene.
Structural variants
There are few characterized structural variants in FVB/NJ
in the literature. Two well-known examples include an
approximately 6-kb deletion in Bfsp2 shared with 129
mice that results in alterations in lens optical quality [27],
and a large genomic deletion resulting in the loss of seg-
ments of the T-cell receptor V beta, which has been
shown to confer resistance to collagen-induced arthritis
[6]. We have generated a catalogue of 30,048 structural
variants (≥50 bp), which includes 15,358 deletions and
14,246 insertions, and combinations of SVs with complex
paired-end mapping patterns (Figure 1 and Table 4) as
described in Yalcin et al. [15,28]. To identify structural
variants from basic paired-end mapping patterns and
changes in mapped read depth, we used BreakDancer
[29], CND [30], SECluster (unpublished) and RetroSeq
[31] in the SVMerge [32] pipeline (Database of Genomic
Variants archive accession estd200). Using the de novo
assembly pipeline in SVMerge with reads surrounding
breakpoints, we were able to refine the breakpoint coor-
dinate predictions for 85% of the SVs. Similar to the gen-
omes of the classical inbred strains sequenced by the
MGP [14], structural variants affect less than 2% of the
FVB/NJ genome. There are 328 SVs that overlap with
protein-coding regions of 415 genes (149 of these genes
Table 3 Non-synonymous single nucleotide variants unique to FVB/NJ, relative to the 17 Mouse Genomes Project






9 119518884 C/A ENSMUSG00000034533 Scn10a Sodium channel, voltage-gated, type X, alpha 205
4 138523178 G/T ENSMUSG00000070661 Rnf186 Ring finger protein 186 205
19 13485488 G/T ENSMUSG00000063777 Olfr1469 Olfactory receptor 1469 205
7 19600268 T/C ENSMUSG00000040891 Foxa3 Forkhead box A3 194
15 101542878 C/A ENSMUSG00000061527 Krt5 Keratin 5 184
9 85738244 C/T ENSMUSG00000035274 Tpbg Trophoblast glycoprotein 180
7 112715121 G/A ENSMUSG00000037032 Apbb1 Amyloid beta (A4) precursor protein-binding, family B, member
1
180
6 43230658 C/T ENSMUSG00000033542 Arhgef5 Rho guanine nucleotide exchange factor (GEF) 5 180
2 84642975 C/T ENSMUSG00000027078 Ube2l6 Ubiquitin-conjugating enzyme E2L 6 180
19 3356468 C/T ENSMUSG00000024900 Cpt1a Carnitine palmitoyltransferase 1a, liver 180
19 16100043 C/T ENSMUSG00000049247 Rpl37-ps1 Ribosomal protein 37, pseudogene 1 180
4 118859970 C/G ENSMUSG00000028644 Ermap Erythroblast membrane-associated protein 177
1 152466145 C/A ENSMUSG00000066842 Hmcn1 Hemicentin 1 160
19 13137960 G/T ENSMUSG00000060593 Olfr1454 Olfactory receptor 1454 159
19 12566519 C/A ENSMUSG00000039982 Dtx4 Deltex 4 homolog (Drosophila) 159
18 14002581 C/A ENSMUSG00000024420 Zfp521 Zinc finger protein 521 159
9 38623499 C/T ENSMUSG00000043911 Olfr922 Olfactory receptor 922 155
1 168031022 T/A ENSMUSG00000026564 Dusp27 Dual specificity phosphatase 27 (putative) 152
The C57BL/6J reference allele and FVB/NJ allele are shown (Ref/FVB). Predicted genes with unknown function are excluded. Gene IDs, names, and descriptions
are from Ensembl version 64. GMS, Grantham matrix score.
Table 2 Enrichment of PANTHER ontology terms from a list of 394 genes with radical amino acid substitutions
(Grantham matrix score >150)
PANTHER term Genes Percentage of total Fold enrichment P-value
MF00002:G-protein coupled receptor 36 9.7 2.2 1.50E-03
MF00001:Receptor 50 13.4 1.7 4.10E-02
MF00224:KRAB box transcription factor 20 5.4 2.8 4.50E-03
Values were calculated using the Database for Annotation, Visualization and Integrated Discovery (DAVID) web-based tools [24,25]. The background gene list
used to determine enrichment is all genes in the mouse genome. The P-value refers to the enrichment P-value, which is a modified Fisher’s exact test. A
Bonferroni multiple testing correction has been applied.
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are deleted or duplicated in their entirety); however,
almost half (199) of these genes are annotated as ‘pre-
dicted genes’. Functional annotation of the 415 genes
using the DAVID web-based tools revealed a significant
enrichment (P <0.01) of genes associated with the
PANTHER gene ontology terms ‘Defense/immunity pro-
tein,’ ‘Immunoglobulin’ and ‘Immunoglobulin receptor
family member’ after a Bonferroni correction was applied.
When compared to the 17 strains sequenced in the
MGP, 8,060 SVs in FVB/NJ were not identified in any
other strain, with the majority (6196, 76.8%) of these being
insertions. This list is likely to be composed of true private
FVB/NJ insertions, true insertions in FVB/NJ that were
missed in one or more of the 17 MGP strains, and false
insertion calls. We used two software programs to call
insertions: RetroSeq [31] and SECluster (unpublished)
(Materials and methods). In order to estimate the false dis-
covery rate of our insertion calls, we randomly selected 50
insertions from calls made by both RetroSeq and SEClus-
ter and 50 insertions each from calls made exclusively by
RetroSeq and SECluster for PCR validation, giving 150
insertions in total. An insertion in the FVB/NJ genome
was not observed for 6 of the 120 (5%) primer pairs that
produced a band in both the reference C57BL/6J and
FVB/NJ. From this we can infer that the majority of the
approximately 8,000 insertions observed in FVB/NJ and
not the 17 MGP strains are likely to be real. The false
negative rates from the MGP showed that insertions were
more difficult to identify than deletions, with false negative
rates ranging from 24% to 32% for insertions, compared to
15% to 20% for deletions in 7 founder strains of the het-
erogeneous stock [15]. Therefore, a large portion of the
approximately 8,000 insertions present only in FVB/NJ
may be false negatives in one or more of the 17 MGP
strains, rather than true private insertions. Several factors
contribute to our improved sensitivity for identifying large
insertions in FVB/NJ, compared to the MGP: higher
sequencing depth (approximately 50× coverage compared
to an average 25×), longer read length (100-bp HiSeq
reads compared to primarily 54- to 76-bp Genome Analy-
zer II reads), and improvements in read alignment algo-
rithms (BWA versus MAQ). Additionally, both RetroSeq
and SECluster were also used in the MGP; however, both
software have been adapted to take advantage of the addi-
tional information provided by both the longer reads and
the ability of BWA to align portions of reads that flank
insertion breakpoints (Materials and methods).
Characterization of two narrowed regions in the Ath11
QTL
The search for genes of interest in QTL mapping experi-
ments involving FVB/NJ mice is greatly facilitated by
having a complete catalogue of genome-wide variants. To
this end, we have re-examined a QTL for atherosclerosis
susceptibility on chromosome 10, Ath11. QTLs for ather-
osclerosis susceptibility have been identified on chromo-
somes 1, 10, 14, 15 and 18 using inter-crosses between
C57BL/6J (atherosclerosis-susceptible) and FVB/NJ
(atherosclerosis-resistant) mice on Apoe-/- and Ldlr-/-
knockout backgrounds [33-35]. Further studies of Ath11
using subcongenic mice allowed Wolfrum et al. [34] to
refine the congenic interval (58.3 Mb) into two smaller
regions, 10a (7.3 Mb), which is female-specific with 21
genes, and 10b (1.8 Mb), which contains 7 genes and is
operative in both genders. The authors also examined
differential expression of genes in these intervals using
aortic tissues from F1 offspring. Wolfrum et al. searched
for candidate causative SNPs in the two regions by
mining public data resources (primarily dbSNP128) for
sites at which C57BL/6J and FVB/NJ differed. They iden-
tified 22 SNPs affecting coding regions, intronic splice
sites, or 5’ or 3’ UTRs. Additionally, they identified 31
potentially polymorphic sites, those which are known to
be polymorphic but of unknown genotype in FVB/NJ.
The authors listed genes of interest in the 10a and 10b
regions as those on the Cardiovascular Gene Ontology
Annotation Initiative’s list of cardiovascular-associated
genes: Ipcrf1, Oprm1, Mtrf1l, Syne1, Esr1, Mthfd1l,
Pde7b, Myb, Aldh8a1, and Sgk1. The Esr1 gene, estrogren
receptor a, in the 10a female-specific region was noted as
a promising candidate gene, as it was identified as a regu-
lator of one of the two gene networks identified from
differentially expressed genes in the aortas of atherosclero-
sis-resistant and atherosclerosis-susceptible congenic mice.
However, their database search revealed only one synon-
ymous SNP and one potential synonymous SNP between
FVB/NJ and C57BL/6J in Esr1. Aldh8a1, which was differ-
entially expressed between congenic strains, was found to
have one synonymous SNP and one 3’ UTR SNP, but did
not have any non-synonymous SNPs. In the 10b region,
Table 4 Structural variants in the FVB/NJ genome
Deletion Duplication Inversion Insertion Deletion in gain Deletion + insertion Inversion + deletion or insertion
Total 15,358 137 67 14,246 58 111 71
Genes 280 109 1 20 2 0 4
Listed are the number of SVs by type, and the number of genes with at least one protein-coding exon overlapping a SV. The following SV types involve more
than one SV and have been described by Yalcin et al. [15,28]: a ‘deletion in gain’ is a deletion that is found within a duplicated region; a ‘deletion plus insertion’
is a deletion that co-occurs with an insertion; and an ‘inversion plus a deletion or insertion’ is an inversion flanked by one or more deletions or insertions.
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only one non-synonymous SNP was found in Myb, and
another potential non-synonymous SNP was found in
Hbs1l, while the remaining SNPs were synonymous SNPs
or affected an intronic splice site or 5’ or 3’ UTRs.
With the FVB/NJ genome sequence, we now have a
comprehensive catalogue of SNPs for these regions, in
addition to indels and structural variants (Figure 2). In
the 10a and 10b regions, we have identified approxi-
mately 2,750 indels, 101 SVs, and 14,211 SNPs, which is
approximately four times more SNPs than dbSNP128
contains for FVB/NJ in these regions. Of the known poly-
morphic sites in genes listed in Wolfrum et al. [34], only
2 out of 22 SNPs were not identified in our call set. Both
of these SNPs had been filtered out of our call set due to
their location in a region with high read depth (Materials
and methods). We were also able to verify that only 8 of
the 31 potentially polymorphic sites Wolfrum et al. iden-
tified do indeed differ between FVB/NJ and C57BL/6J
(Table s4 in Additional file 1), significantly decreasing
the number of candidate causative SNPs.
From our catalogue of variants, we have identified 12
additional non-synonymous SNPs in the 10a and 10b
regions of the FVB/NJ genome (Table 5 and Figure 2).
Eight of the 12 sites have previously been described as poly-
morphic in other mouse strains (dbSNP128), and all 12
SNPs are also present in at least one of the other 17 strains
from the MGP. In the 10a region, we identified a single
non-synonymous SNP in the ligand-binding domain of
ENSMUSP00000101213, which is one of five protein
products encoded by Esr1. We have also identified
Figure 2 SNPs, indels, and structural variants (SVs) in the FVB/NJ mouse, in two narrowed regions of the chromosome 10 Ath11 locus.
(a) The 10a locus from 1 to 7.3 Mb. (b) The 10b locus from 20.1 to 21.9 Mb. (c) Within the 10a region is the Mthdf1l gene, with non-
synonymous and synonymous SNPs shown. Shown in red are non-synonymous SNPs or SNPs that affect intronic splice sites. In green are
synonymous SNPs. In blue are gene models based on Ensembl version 64. Previously known FVB/NJ SNPs from dbSNP version 128 are also
shown. The 10a region displayed in (a) begins at 3 Mb since the sequence from 1 bp to 3 Mb has not been assembled in the reference
genome. Shown in the 10b region are the genes described in Wolfrum et al. [34] (Pde7b, Ahi1, Myb, Hbs1l, Aldh8a1, Sgk1), and additional
predicted genes from Ensembl (1700020N01Rik, 1700021A07Rik, Gm5420, 4930444G20Rik, E030030I06Rik).
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non-synonymous SNPs in three other genes, Zbtb2, Lrp11
and Mthfd1l, which had been omitted as genes of interest
due to the lack of comprehensive SNP data. The two sub-
stitutions inMthfd1l (Figure 2c) may be functional, as they
fall inside of the binding domain and catalytic domain of
this enzyme. This is an interesting gene candidate since
SNPs in the human ortholog, MTHFD1L, have been asso-
ciated with disease [36-38], including coronary artery dis-
ease [39-42]. No structural variants appear to affect
protein-coding regions in 10a, although a total of 27 inser-
tions and deletions fall in introns of 11 genes. In the 10b
region, there is one non-synonymous SNP in Aldh8a1
that affects one of the two protein-coding transcripts.
The SNP is located in the first base of the last exon in
ENSMUST00000159163. This transcript, however, is based
on a single expressed sequence tag (EST BI145926.1) and
the coding sequence start and end have not been anno-
tated. Non-synonymous SNPs are also present in the
Ensembl predicted protein-coding genes 4930444G20Rik
and E030030I06Rik, and an indel also deletes four codons
in the 4930444G20Rik gene. Manual inspection of these
genes, however, revealed that E030030I06Rik and 4930-
444G20Rik are both pseudogenes. Here we have focused on
variants in coding regions, although we also identified
467 variants in proximal promoter regions (within 5 kb
upstream of a gene). Our catalogue of SNPs, indels, and





dbSNP ID MGP Gene name, Ensembl gene ID and
description
Trans. Protein domain
5016217 G/C None 8 Syne1
ENSMUSG00000019769
Synaptic nuclear envelope 1
1/4 Spectrin repeat
5380387 C/A rs29315913 13 Esr1
ENSMUSG0000001976
Estrogen receptor 1
1/5 Nuclear hormone receptor, ligand-binding,
core
5977100 A/C None 16 Zbtb2
ENSMUSG00000075327
Zinc finger and BTB domain containing 2
2/2 None
6338741 A/G rs29378605 15 Mthfd1l
ENSMUSG00000040675
Methylenetetrahydrofolate dehydrogenase
(NAD P+ dependent) 1-like
3/3 Tetrahydrofolate dehydrogenase/
cyclohydrolase, NAD(P)-binding domain
6367833 A/G rs29320259 14 Mthfd1l
ENSMUSG00000040675
Methylenetetrahydrofolate dehydrogenase
(NAD P+ dependent) 1-like
3/3 Tetrahydrofolate dehydrogenase/
cyclohydrolase, catalytic domain
7309964 T/C rs29376214 6 Lrp11
ENSMUSG00000019796
Low density lipoprotein receptor-related
protein 11
4/6 Polycystic Kidney Disease(PKD) domain
21108744 A/G rs49757404 12 Aldh8a1
ENSMUSG00000037542
Aldehyde dehydrogenase 8 family
1/2 Aldehyde dehydrogenase domain
21787374 C/T rs47037014 8 4930444G20Rik
ENSMUSG00000069712
RIKEN cDNA 4930444G20 gene
1/1 None
21787451 A/C rs50088182 9 4930444G20Rik
ENSMUSG00000069712
RIKEN cDNA 4930444G20 gene
1/1 None
21864292 C/T rs49453000 8 E030030I06Rik
ENSMUSG00000055657
RIKEN cDNA E030030I06 gene
1/1 None
21868313 T/C None 9 E030030I06Rik
ENSMUSG00000055657
RIKEN cDNA E030030I06 gene
1/1 None
21868315 T/A None 9 E030030I06Rik
ENSMUSG00000055657
RIKEN cDNA E030030I06 gene
1/1 None
Wolfrum et al. [34] characterized two narrowed regions, 10a and 10b, within Ath11 containing 28 genes. This table describes additional non-synonymous SNPs
discovered by sequencing of the FVB/NJ genome. Listed are the reference allele and FVB/NJ allele (Ref/FVB), the dbSNP ID (build 128) for sites previously identified
as polymorphic in other mouse strains, and the number of strains in the Mouse Genomes Project (MGP) with the same allele as FVB/NJ. Also listed is the number of
protein-coding transcripts (Trans.) affected and the protein domain involved. Gene and protein domain models were obtained from Ensembl version 64.
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SVs now provides the critical information for the functional
analyses required to reveal the underlying factors responsi-
ble for atherosclerosis susceptibility in this QTL.
Conclusions
We have sequenced the FVB/NJ mouse genome and cata-
logued SNPs, indels, and SVs. For SNPs alone, our study
has increased the number of known variant sites by a fac-
tor of four for the FVB/NJ strain and therefore will serve
as a valuable resource, as the FVB/NJ mouse strain is
widely used for the generation of transgenic mice and in
QTL mapping. We have shown how this resource can be
used to characterize a QTL, accelerating the identification
of candidate causal variants.
Materials and methods
DNA sequencing and read alignment
FVB/NJ DNA was obtained from the Jackson Laboratories
(#1800; pedigree: 10-00964; generation: F95pF98) from a
female FVB/NJ mouse. DNA (1 to 3 μg) was sheared to
100 to 1,000 bp using a Covaris E210 or LE220 (Covaris,
Woburn, MA, USA) and size selected (350 to 450 bp)
using magnetic beads (Ampure XP; Beckman Coulter).
Sheared DNA was subjected to Illumina paired-end DNA
library preparation and PCR-amplified for six cycles.
Amplified libraries were sequenced using the HiSeq plat-
form (Illumina) as paired-end 100 base reads according to
the manufacturer’s protocol. Each sequencing lane was
genotype checked against the Perlegen SNP calls using the
SAMtools programs BCFtools/glfTools [20]. A list of
libraries and sequencing statistics is available in Table s5
in Additional file 1.
Sequencing reads from each lane were aligned to the
C57BL/6J reference genome (NCBI build M37/mm9)
using BWA version 0.5.9-r16 and the parameters ‘-q 15
-t 2’. To improve SNP and indel calling, the GATK [19]
‘IndelRealigner’ was used to realign reads near indels
from the MGP [14]. The BAM files were then re-sorted
and quality scores were recalibrated using GATK ‘Table-
Recalibration’. Finally, SAMtools ‘calmd’ was used to
recalculate MD/NM tags in the BAM files. All lanes from
the same library were then merged into a single BAM file
using Picard tools [43] and PCR duplicates were marked
using Picard ‘MarkDuplicates’. Finally, the library BAM
files were merged into a single BAM containing all FVB/
NJ sequencing reads.
SNP and indel discovery, and prediction of consequences
SNPs and indels were identified using the SAMtools mpi-
leup function, which finds putative variants and indels
from alignments and assigns likelihoods, and BCFtools
[20], which applies a prior and performs the variant call-
ing. The following parameters were used: for SAMtools
mpileup ‘-EDS -C50 -d 1000’ and for BCFtools view ‘-p
0.99 -vcgN’.
Variants and indels were filtered using ‘vcf-annotate’
from the VCFtools package [44]. Filters and cutoff values
are listed in Table s6 in Additional file 1. These filters are
designed to identify inaccessible or uncallable sites and
remove false SNP and indel calls due to alignment arti-
facts. Only homozygous SNPs and indels were retained.
To determine the effect of variants and indels on tran-
scripts, we used the Ensembl Variant Effect Predictor tool
version 2.2 [23] against mouse gene models from Ensembl
version 64. Grantham scores were also generated to pre-
dict the impact of the amino acid substitutions.
SNPs and indels that are unique to FVB/NJ were identi-
fied by realigning the 17 MGP data using BWA, and per-
forming recalibration and realignment around indels, as
described above for the FVB/NJ data. The 17 MGP strains
were then genotyped at all FVB/NJ SNP and indel sites
using the SAMtools mpileup and BCFtools pipeline
described above. To obtain a list of high confidence private
FVB/NJ SNPs, we required each site to be genotyped as a
homozygous reference allele in all 17 MGP strains, with a
genotype quality of at least 30 and supporting read depth
of 5 or more reads. The same criteria were applied to find
private FVB/NJ indels.
Sequenom validation
Genotyping was performed using the iPLEX™ Gold
Assay (Sequenom® Inc.) [21]. Assays for all SNPs were
designed using the eXTEND suite and MassARRAY
Assay Design software version 3.1 (Sequenom® Inc.).
Primers were designed from 100 bp of sequence flank-
ing the SNP or indel of interest; FVB/NJ SNPs and
indels in the flanking regions were masked, in addition
to repetitive regions. Amplification was performed in a
total volume of 5 μl containing approximately 10 ng
genomic DNA, 100 nM of each PCR primer, 500 μM of
each dNTP, 1.25× PCR buffer (Qiagen Crawley, West
Sussex, UK), 1.625 mM MgCl2 and 1U HotStar Taq
®
(Qiagen). Reactions were heated to 94°C for 15 minutes
followed by 45 cycles at 94°C for 20 s, 56°C for 30 s and
72°C for 1 minute, then a final extension at 72°C for 3
minutes. Unincorporated dNTPs were SAP digested
prior to iPLEX™ Gold allele specific extension with
mass-modified ddNTPs using an iPLEX Gold reagent kit
(Sequenom® Inc.). SAP digestion and extension were
performed according to the manufacturer’s instructions
with reaction extension primer concentrations adjusted
to between 0.7 and 1.8 μM, dependent upon primer
mass. Extension products were desalted and dispensed
onto a SpectroCHIP using a MassARRAY Nanodispen-
ser prior to MALDI-TOF analysis with a MassARRAY
Analyzer Compact mass spectrometer. Genotypes were
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automatically assigned and manually confirmed using
MassARRAY TyperAnalyzer software version 4.0
(Sequenom® Inc.).
Estimation of false positive and false negative rates
The false positive rate for SNP and indel discovery in
FVB/NJ was estimated by randomly selecting 150 SNPs
and 100 indels for genotyping in FVB/NJ and C57BL/6J
using the Sequenom MassARRAY iPLEX Gold Assay
[9], as described above. A genotype call was made for
128/150 SNPs and 69/100 indels. The concordance rate
was 98.4% (126/128) for SNPs and 89.9% (62/69) for
indels, giving false positive rates of 1.6% and 10.1%,
respectively. However, one of the two discordant calls
was due to a heterozygous call from the iPLEX Gold
Assay. As we expect SNPs in inbred mice to be homozy-
gous, this is likely to be an erroneous genotype call. We
excluded this site to calculate the lower boundary of our
SNP false positive rate, 0.8% (1/127 discordant calls).
We also selected 111 private FVB/NJ SNPs, of which
103 genotype calls were made. The private SNPs chosen
for genotyping only included non-synonymous SNPs,
SNPs that create premature stop codons, or SNPs affect-
ing splice sites. The concordance rate was 94.2% (97/
103). Three of the discordant calls were heterozygous
calls by the iPLEX Gold Assay, and excluding these calls
gives a concordance rate of 97% (97/100).
We compared our catalogue of FVB/NJ SNP calls to
FVB/NJ genotypes from the Perlegen/NIEHS data set [22].
There are 996,981 sites genotyped as homozygous non-
reference SNPs in this data set, and of these, 91.7%
(914,225) are present in our FVB/NJ catalogue. Of the
remaining, 2.7% (26,869) fell into ‘uncallable’ sites (see
Materials and methods above) and 5.6% (55,887) were not
in our SNP catalogue. We randomly selected 100 SNP sites
from the 5.6% discordant sites for SNP genotyping using
the iPLEX Gold Assay. Of the 93 that produced genotype
calls, 90 sites (96.8%) were genotyped as homozygous refer-
ence alleles. Assuming that this portion of the 5.6% discor-
dant genotypes are homozygous reference bases, then our
false negative rate at accessible sites in the Perlegen/NIEHS
data set is less than 1%. Two of the three discordant geno-
types were called by the iPLEX Gold Assay as heterozygous
SNPs in the FVB/NJ sample.
Structural variant discovery
SVs were identified using SVMerge [32], in which we
applied a combination of BreakDancer [29], CND [30],
RetroSeq [31] and SECluster (unpublished), followed by
filtering and local sequence assembly for all deletions and
insertions (from SECluster) to obtain exact breakpoints,
all as described previously [15,28]. For this analysis,
SECluster was optimized to work with reads mapped
with BWA [18] by including mate pairs with one mate
soft-clipped and read pairs with non-inward facing orien-
tation for read clustering and insertion calling. RetroSeq
was also updated to include soft-clipped reads in the
breakpoint resolution step. The parameters for all SV
callers are shown in Table s7 in Additional file 1.
Tandem duplications, inversions, and more complex
paired-end mapping patterns were also identified using
in-house Perl scripts, as described in Yalcin et al. [28].
Mouse genome reference assembly gaps, centromere and
telomere regions were obtained from the University of
California Santa Cruz Table Browser [45]. Structural var-
iants overlapping these regions, plus a window on either
side of 500 bp for assembly gaps and 20 kb for centro-
meres and telomeres, were excluded, as mapping artifacts
in these regions cause false SV calls.
DAVID analysis
For analysis of genes with radical amino acid substitutions,
a list of 394 Ensembl gene IDs was submitted to the
DAVID website [24,25] (version 6.7) for functional anno-
tation, and 368 mapped to genes in their database. For
structural variants overlapping genes, a list of 415 Ensembl
gene IDs was submitted to the DAVID website, and 331
mapped to genes in their database. The default EASE
threshold score was used (0.1) and the minimum number
of genes for a term was set to 2.
Primer design and PCR analysis
PCR primers to validate insertions were designed using
Primer3 release 2.2.3 [46] and an in-house Perl script. The
optimal primer length was set at 20 bp and all other Pri-
mer3 defaults were used. FVB/NJ SNP sites and structural
variants were masked. Primers were designed to have a
product size between 200 and 1,000 bp, relative to the
reference genome. Candidate primer pairs were checked
for uniqueness in the mouse reference genome, and inser-
tions with no unique primer pairs were excluded from
validation.
PCR was performed on C57BL/6J and FVB/NJ genomic
DNA (The Jackson Laboratory, Bar Harbor, Maine, USA)
using either Thermo-Start Taq DNA Polymerase (Abgene,
Epsom, UK) with an annealing temperature of 60°C and
extension time of 30 s (for 35 cycles) or Platinum® Taq
DNA Polymerase High Fidelity (Life Technologies Limited,
Paisley, UK) with an annealing temperature of 60°C and
extension time of 5 to 8 minutes (for 35 cycles), according
to the manufacturers instructions. The PCR products were
run on 1 to 2% agarose gels containing ethidium bromide,
and visualized using a UV transilluminator. The approxi-
mate sizes of the PCR products were calculated by running
molecular weight markers (Hyperladder™ I; Bioline
Reagents Limited, London, UK) on each gel.
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Comparison of SNPs in at the Ath11 locus
We used the BioMart tool from Ensembl build 64 to
retrieve genotypes for the FVB/NJ strain in the chromo-
some 10 Ath11 10a and 10b regions, from positions 1 to
7,300,000 bp and 20,100,000 to 21,900,000 bp. We queried
the Ensembl Mus musculus Variation 64 database, which
is generated from dbSNP Build 128 [47]. From this list we
identified sites with non-reference alleles, and compared
these variants to the set of FVB/NJ variants we generated
as described above.
Additional material
Additional file 1: Supplemental tables.
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